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Background. Women over 70 with breast cancer have poorer one-year survival and present at a more advanced stage than
younger women. Promoting early symptomatic presentation in older women may reduce stage cost eﬀectively and is unlikely
to lead to overdiagnosis. After examining eﬃcacy in a randomised controlled trial, we piloted a brief health professional-delivered
intervention to equip women to present promptly with breast symptoms, as an integral part of the final invited mammogram at
age ∼70, in the English National Health Service Breast Screening Programme. Methods. We trained mammographers, who then
oﬀered the intervention to older women in four breast screening services. We examined breast cancer awareness at baseline and
one month in women receiving the intervention, and also in a service where the intervention was not oﬀered. Results. We trained
27 mammographers to deliver the intervention confidently to a high standard. Breast cancer awareness increased 7-fold at one
month in women receiving the intervention compared with 2-fold in the comparison service (odds ratio 15.2, 95% confidence
interval 10.0 to 23.2). Conclusions. The PEP Intervention can be implemented in routine clinical practice with a potency similar to
that achieved in a randomised controlled trial. It has the potential to reduce delay in diagnosis for breast cancer in older women.
1. Introduction
Older women with breast cancer have poorer one-year rel-
ative survival than younger women [1] and are more likely
to be diagnosed with advanced stage of disease [2]. Older
age is a risk factor for delay in presentation in breast cancer
[3]. Women over the age of 73 are not routinely invited for
screening on the English National Health Service (NHS)
Breast Screening Programme; most women with breast can-
cer of this age group therefore present symptomatically.
We have developed a brief intervention to promote early
symptomatic presentation of breast cancer in older women
(the Promoting Early Presentation (PEP) Intervention) [4].
It is a scripted one-to-one intervention, delivered to an older
woman in a positive, collaborative, and motivational style by
a health professional, providing the knowledge, motivation,
confidence, and skills to present promptly on discovering a
breast symptom. It is supported by a booklet which women
are given to take home.
The PEP Intervention increased breast cancer awareness
fourfold compared with usual care for up to two years in
a randomised controlled trial, in which it was delivered by
research health professionals [5, 6], and the eﬀect was sus-
tained after three years (report in preparation). The eﬀect
was greater than any other intervention of its kind [7].
The NHS Breast Screening Programme currently invites
women aged 50–70 for two-view mammography every three
years and a national randomised controlled trial of inviting
women aged 47–49 and 71–73 is currently under way.
The final invited mammogram provides an opportunity to
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promote early presentation to women at increasing risk of
developing breast cancer, but no longer routinely invited for
screening, at whatever age that may be. By promoting early
symptomatic presentation, the PEP Intervention may reduce
stage of breast cancer at diagnosis and is unlikely to lead to
overdiagnosis: among women aged 70 and over, breast symp-
toms are very likely to be due to breast cancer [8].
We aimed to examine whether we could train NHS rather
than research staﬀ to deliver the PEP Intervention, whether
quality of delivery could be maintained, and whether the
eﬀect on breast cancer awareness shown in the randomised
controlled trial could be replicated in routine clinical prac-
tice. We piloted the PEP Intervention, which takes about five
minutes, delivered by NHS mammographers as an integral
part of the final invited mammogram appointment in four
breast screening services.
2. Methods
2.1. Training to Deliver PEP Intervention. During 2011, we
oﬀered training to deliver the PEP Intervention to all 63
mammographers (both radiographers and assistant practi-
tioners working in four breast screening services (Cambridge
and Huntingdon; Warwickshire, Solihull and Coventry;
Maidstone; Medway)). The facilitator-led training involved
two half-day group sessions, two to four weeks apart, plus
practice sessions with performance feedback in-between pro-
vided by coaching radiographers. The training team, includ-
ing the facilitator and coaching radiographers, assessed
competence to deliver the PEP Intervention during and at
the end of training by completing a checklist of quality
criteria (see the appendix) during observed interventions.
The coaching radiographer calculated a quality score for each
intervention for content out of 33 and for style out of 6
and converted these to percentages. A satisfactory score was
considered to be 70% for content and 50% for style. Having
identified strong and weak areas of quality of delivery, the
coaching radiographer undertook a performance feedback
session with the mammographer. Twelve of the criteria were
considered the most important (nine for content and three
for style (marked “essential” and “desirable” on the checklist
(see the appendix))) and so performance feedback focused
mainly on these.
Wemeasuredmammographers’ confidence to deliver key
messages about early presentation before and immediately
after training, using a self-complete questionnaire including
seven questions answered on a scale of 1–10. We calculated
mean scores out of ten for each question before and after
training.
2.2. Delivering the PEP Intervention. During the implemen-
tation period (between three and six months in each service
between May 2011 and February 2012), women attending
for final mammogram were allocated longer appointments
and oﬀered the PEP Intervention on arrival. The PEP
Intervention was delivered as an integral part of the final
invited mammogram in the X-ray room.
We implemented a quality assurance programme to
ensure consistently high-quality delivery of the PEP Inter-
vention. This involved a coaching radiographer assessing, for
each mammographer, an audiotaped intervention every
two weeks, and a directly observed intervention every two
months, using the checklist of quality criteria (see the appen-
dix). The coaching radiographer assessed quality and used
this as the basis for a fifteen-minute performance feedback
session as described in the section on training to deliver the
PEP Intervention.
2.3. Evaluating the Eﬀect of the PEP Intervention on Breast
Cancer Awareness. Evaluating the eﬀect of the PEP Inter-
vention on breast cancer awareness involved the four pilot
services and two comparison services which did not oﬀer
the PEP Intervention (Norwich and Norfolk and Gateshead
Breast Screening Services). Women were sent information
about the evaluation with their final invited screening
appointment letter three weeks before their appointment.
Mammographers invited eligible women to take part when
they attended, and if they consented, they were asked to
complete a short questionnaire. One month later we sent
them the same questionnaire by post.
The questionnaire included a validated measure of breast
cancer awareness [9]. This measured knowledge of breast
cancer symptoms, knowledge that the risk of breast cancer
increases with age and of lifetime risk of breast cancer,
reported breast checking, confidence to detect a breast
change, and barriers to seeing a doctor with a health prob-
lem.Women were also asked to provide ethnic group, wheth-
er they lived with a husband or partner and age of leaving
full time education. Breast screening services provided date
of birth and postcode.
Breast cancer awareness data collection in the pilot
services took place over May 2011 to April 2012 and in the
comparison services over March 2011 to January 2012. We
compared change in breast cancer awareness over one month
in women receiving the PEP Intervention in the pilot services
with that of women in the comparison services.
We assigned each woman taking part in the evaluation
an Index of Multiple Deprivation score (IMD) (2007) based
on the area of residence used in the Census 2001 (higher
scores indicate more socioeconomic deprivation: the IMD
summarises income, employment, health and disability, edu-
cation and skills, housing, service access, living environment,
and experience of crime, based on a range of routine data
sources, for a geographical area). We examined demographic
diﬀerences between women who received the PEP Interven-
tion and women in the comparison services and between
women who responded at one month and women who
responded at baseline only.
Women were considered breast cancer aware if they knew
that risk of breast cancer increased with age, recognised five
or more nonlump symptoms of breast cancer, and reported
checking their breasts at least once a month.
We used repeated measures logistic regression models to
examine change in breast cancer awareness from baseline to
one month comparing women who received the PEP Inter-
vention with women in the comparison services, including
only those who provided data at both time points. We
examined the eﬀect on the odds ratios of controlling for
demographic diﬀerences between the groups.






































































Figure 1: Mammographers’ mean confidence scores before and after training.
We carried out semistructured interviews with mammo-
graphers several weeks after training to gain their impres-
sions of training, coaching, performance feedback and deliv-
ery of the intervention, and how they felt it had contributed
to their professional development.
The project received ethics approval from the Cam-
bridgeshire 1 Research Ethics Committee (10/H0304/90).
3. Results
Thirty two mammographers started and 27 completed the
training programme (five did not complete it because of
health problems and family commitments). At the end of
training, all 27 were delivering the PEP Intervention to a
satisfactory level (70% or more for content and 50% or more
for style). Mean confidence scores for all seven questions
increased over the training period (Figure 1).
Eight hundred and thirty women were oﬀered the PEP
Intervention (25% of women attending for their final invited
mammogram at the four services) and 551 (66%) took
it up. Nineteen mammographers ultimately delivered these
interventions—eight were not able to for a variety of per-
sonal and service reasons. Quality of delivery was well main-
tained for these 19 mammographers: based on fortnightly
assessments, mean scores for content never fell below 80%
and mean scores for style never fell below 70%.
In the pilot services, 511 women were asked to participate
in the evaluation of breast cancer awareness; 495 (97%)
agreed to take part and completed a baseline questionnaire.
Four hundred and fifty seven (92%) women also completed
the one-month questionnaire. In one of the comparison
services, 880 (64%) women attending for final invited
mammogram agreed to take part and completed the baseline
questionnaire; 789 (90%) women also completed the one-
month questionnaire. In the other comparison service, only
82 (36%) women attending for their final invited mam-
mogram agreed to take part and completed the baseline
questionnaire. This is likely to have been because mammo-
graphers found it diﬃcult to recruit women due to ongoing
service developments, in particular the introduction of digi-
tal mammography. We did not include the women attending
this service in the analysis because of the low response rate.
Women who responded at both time points were more
likely to be White and slightly less likely to live in socioe-
conomically deprived areas than women who responded at
baseline only (White: 98% versus 94%, P < 0.001; median
IMD 11.1 versus 12.0, P = 0.03).
Table 1 shows the demographic characteristics of partic-
ipating women. Most were White and lived with a husband
or partner. Women who received the PEP Intervention were
slightly older, less likely to be living with a husband or
partner, more likely to have left school after the age of 18, and
less likely to be living in socioeconomically deprived areas
than women in the comparison service.
Table 2 shows change in breast cancer awareness and con-
fidence to notice a breast change in the women who received
the PEP Intervention and the women in the comparison
service. Women who received the PEP Intervention had a
much greater increase in breast cancer awareness than the
comparison group. The increase was seen for all components
of the score: women who received the PEP Intervention were
more likely to recognise five or more nonlump symptoms of
breast cancer, to know that a 70-year-old woman was most
at risk of breast cancer compared to a 30- or 50-year-old
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Table 1: Characteristics of women participating in the evaluation.
Women in comparison service
n = 875
Women receiving PEP Intervention
n = 495
Mean age 68 years, 9 months 71 years, 4 months P < 0.001
Living with husband or partner 670 (76.6%) 340 (68.7%) P < 0.001
Left full time education aged 19 or older 88 (10.1%) 109 (22.0%) P < 0.001
White ethnic group 854 (97.6%) 484 (97.8%) P = 0.42
Median Index of Multiple Deprivation 11.39 8.12 P < 0.001
Table 2: Change in breast cancer awareness and confidence to notice a breast change.
Comparison service (n = 789) PEP Intervention (n = 457)
Crude odds ratio (95% confidence interval)
Baseline One month Baseline One month
Breast cancer aware 24 (2.9%) 30 (3.9%) 19 (4.2%) 167 (37.7%) 15.24 (10.0 to 23.2)
Knew five or more
nonlump symptoms
457 (52.2%) 461 (59.3%) 244 (52.8%) 373 (82.5%) 3.26 (2.48 to 4.30)
Knew that risk of breast
cancer increases with age
70 (8.2%) 59 (7.6%) 66 (13.3%) 247 (49.9%) 15.39 (11.1 to 21.35)
Reported checking breasts
at least once a month
494 (57.0%) 506 (64.5%) 249 (50.3%) 359 (78.7%) 2.10 (1.61 to 2.73)
Knew lifetime risk of breast
cancer (1 in 8)
419 (49.2%) 372 (47.8%) 244 (50.2%) 272 (60.4%) 1.67 (1.32 to 2.10)
“Fairly” or “very” confident
to notice change in breasts
603 (69.6%) 619 (78.8%) 348 (70.7%) 391 (85.6%) 1.61 (1.19 to 2.19)
woman or a woman of any age and more likely to report
checking their breasts at least once a month than women
in the comparison service after one month. Women who
received the PEP Intervention were also more likely to know
the lifetime risk of breast cancer and to report being “fairly”
or “very confident” that they would notice a change in their
breasts at one month compared with the comparison service.
Adjusting for age, living with a husband or partner, age left
full time education, and IMD made little diﬀerence to the
odds ratios.
Barriers to symptomatic presentation were relatively
rarely reported by the women (Table 3). The most frequently
reported issues making it diﬃcult to see a doctor with a
health problem were feeling that they were bothering their
doctor, finding it diﬃcult to make an appointment and
worrying that the doctor is too busy to listen to them. The
PEP Intervention had limited influence on barriers; the only
statistically significant diﬀerences were very small: women
who received the PEP Intervention were less likely to report
that finding it diﬃcult to make an appointment, that the
doctor was too busy to listen to them, and that it was
physically diﬃcult to get to the surgery than in the compar-
ison group. Adjusting for age, living with a husband or
partner, age left full time education, and IMDmade little dif-
ference to the odds ratios.
In interviews, mammographers were very positive about
training, coaching, performance feedback, and delivery of
the PEP Intervention. They saw the PEP Intervention as
extending their role, enhancing their professional develop-
ment, and they particularly valued the opportunity it gave
them to interact with their clients.
4. Discussion
We successfully piloted implementation of the PEP Inter-
vention in four breast screening services: we trained NHS
mammographers who delivered the intervention confidently
to a high standard, and who were positive about its eﬀect on
their professional development. Uptake of the intervention
was good. The intervention increased breast cancer aware-
ness at one month from 4% at baseline to 38% at one month.
The eﬀect of the intervention on breast cancer awareness
in routine clinical practice is of a similar size as achieved
by the PEP Intervention delivered within the randomised
controlled trial, which increased breast cancer awareness at
one month from 2% at baseline to 33% at one month [6].
The PEP intervention had large eﬀects on all the aspects
of breast cancer awareness. It had a more limited eﬀect on
reported barriers to symptomatic presentation.
Our study shows that the PEP Intervention is as potent
after one month when delivered in routine clinical practice
by NHS staﬀ as when delivered by research radiographers
with very close quality control in a randomised controlled
trial. We were surprised at this finding: interventions,
whether pharmacological or complex, are often less potent
in routine clinical practice than in randomised controlled
trials [10–12]. There are many possible reasons for this,
including that in randomised controlled trials the delivery of
the intervention being tested is strictly controlled, and the
participants are self-selected and more motivated with better
potential for a positive outcome [13]. The success of the PEP
Intervention in routine clinical practice is likely to be due
to a high level of mammographer motivation engendered by
Journal of Cancer Epidemiology 5
Table 3: Change in reported barriers to seeing a doctor with a health problem.
Comparison service (n = 789) PEP Intervention (n = 457)
Crude odds ratio (95% confidence interval)
Baseline One month Baseline One month
I feel that I am bothering
my doctor
74 (8.6%) 89 (11.3%) 63 (12.8%) 50 (11.0%) 0.95 (0.66 to 1.37)
It is usually diﬃcult for me
to get an appointment
67 (7.7%) 99 (12.6%) 32 (6.5%) 30 (6.6%) 0.48 (0.32 to 0.74)
I worry that he/she is too
busy to listen to me
38 (4.4%) 61 (7.8%) 25 (5.1%) 21 (4.6%) 0.59 (0.35 to 0.98)
I worry about any
treatment I might have to
have
27 (3.1%) 43 (5.5%) 28 (5.7%) 24 (5.3%) 0.95 (0.57 to 1.59)
I feel embarrassed to go to
my doctor in case he/she
has to examine me
18 (2.1%) 19 (2.4%) 8 (1.6%) 13 (2.9%) 1.18 (0.57 to 2.43)
I have other more
important things to think
about or do
17 (2.0%) 23 (2.9%) 16 (3.3%) 15 (3.3%) 1.15 (0.60 to 2.18)
It is physically diﬃcult for
me to get to the surgery
10 (1.2%) 13 (1.7%) 3 (0.6%) 1 (0.2%) 0.18 (0.03-0.96)
the training and coaching, and attributes of the intervention
itself, which gives the mammographers an opportunity to
communicate positively with their clients.
We found that the PEP Intervention had little eﬀect on
reported barriers to symptomatic presentation. This may
be at least partly because barriers were rarely reported by
the women. We note that the commonest barrier to early
presentation reported was “I feel I am bothering my doctor,”
reported by about 11% of women. This is less than has been
found in other studies of barriers to symptomatic presenta-
tion asking a similar question, which have found that over
30% of British people reported that worry about wasting
the doctor’s time might put them oﬀ seeing a doctor with
a symptom that might be serious [14, 15].
Our evaluation of the pilot implementation of the PEP
Intervention was not as methodologically robust as the
randomised controlled trial: in the pilot, women were not
randomly allocated to receive the intervention or not, so
those receiving the intervention may have diﬀered in many
ways from those who did not, in the comparison services.
However, adjusting for known diﬀerences between the
women in the intervention and comparison services made
little diﬀerence to the findings. Moreover, the eﬀect size was
so large that variation in outcome between the intervention
and comparison services is unlikely to be due simply diﬀer-
ences between the populations involved.
Implementation was not complete: the services did not
manage to oﬀer the PEP Intervention to all women attending
for final mammogram. This was because not all mam-
mographers were trained to deliver the intervention, and
implementation was limited by the capacity of existing clinics
and availability of temporary staﬀ to backfill the trained
mammographers’ time. Were the intervention to be imple-
mented more widely, it would be necessary to expand capac-
ity of the services to incorporate an extra five minutes for
every woman attending for their final invited mammogram
(about 1 in 7 mammograms delivered).
Uptake of the intervention among women was good,
suggesting that the intervention was an acceptable part of the
mammogram appointment.
Whether increasing breast cancer awareness will reduce
breast cancer mortality is not yet known. The evaluation is
ongoing and will, in due course, report the eﬀect on breast
cancer awareness at one year, self-referral for screening,
symptomatic breast clinic attendances, and breast cancer
mortality. There is indirect evidence that breast cancer
awareness influences mortality: women who delay presenta-
tion in breast cancer are more likely to have poor awareness
of symptoms [3], and delay in diagnosis is related to worse
survival in breast cancer [16].
The UK has worse breast cancer survival than many
countries with good access to high-quality health care [17].
We estimate that 7,000–12,000 women in England delay
presentation for >3 months each year [16, 18]. These women
have 7% lower 5-year survival than those with shorter delays
[16]. This suggests that at least 500 women in England will
die because of delayed presentation each year (assuming a 5-
year breast cancer survival of 80% in women who delay <3
months and 73% in those who delay >3 months). Delivered
to all women attending for their final invited mammogram
on the NHS Breast Screening Programme, at whatever age
that may be, the PEP Intervention could contribute to
improving cancer survival in England so that it is nearer to
that achieved in similar countries.
Appendix
For quality criteria to assess mammographers’ competence to
deliver the intervention see SupplementaryMaterial available
online at doi:10.1155/2012/835167.
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